Get Live Data
Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share Regulatory News
  5. Change of name to GSK plc

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,593.00
Bid: 1,592.50
Ask: 1,593.00
Change: -11.50 (-0.72%)
Spread: 0.50 (0.031%)
Open: 1,613.00
High: 1,613.00
Low: 1,591.50
Prev. Close: 1,604.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of name to GSK plc

16 May 2022 14:00

RNS Number : 6484L
GlaxoSmithKline PLC
16 May 2022
 

GSK plc(the 'Company')

Change of name to GSK plc

The Company today confirms its name has changed from GlaxoSmithKline plc to GSK plc.

The Company announced the decision to change its name to GSK plc on 27 April 2022 together with its first quarter 2022 results. This change has now taken effect.

The London Stock Exchange and the New York Stock Exchange will reflect the change of name in due course. 

Shareholders should note that their shareholdings will be unaffected by the change of name. Existing share certificates should be retained as they will remain valid for all purposes and no new share certificates will be issued.

The ISINs, SEDOLs, CUSIPs and ticker symbols of the Company's ordinary shares and ADS remain unchanged. The Company's Legal Entity Identifier (LEI) remains 5493000HZTVUYLO1D793.

V A WhyteCompany Secretary

16 May 2022

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CANFLFVFEVIRLIF
789101112131415
Date   Source Headline
28th Apr 20215:33 pmRNSDirector/PDMR Shareholding
28th Apr 202112:00 pmRNS1st Quarter Results
26th Apr 20214:14 pmRNSDirector/PDMR Shareholding
23rd Apr 20213:00 pmRNSEU approves GSK’s JEMPERLI (dostarlimab-gxly)
23rd Apr 20217:00 amRNSFDA approves GSK’s JEMPERLI (dostarlimab-gxly)
16th Apr 20214:00 pmRNSDirector/PDMR Shareholding
15th Apr 20213:21 pmRNSDirector/PDMR Shareholding
15th Apr 202110:17 amRNSDirector/PDMR Shareholding
14th Apr 20212:14 pmRNSDirector/PDMR Shareholding
14th Apr 202111:58 amRNSDirector/PDMR Shareholding
12th Apr 20215:32 pmRNSDirector/PDMR Shareholding
12th Apr 20219:48 amRNSDirector/PDMR Shareholding
9th Apr 20215:34 pmRNSDirector/PDMR Shareholding
9th Apr 20211:35 pmRNSDirector/PDMR Shareholding
6th Apr 20212:30 pmRNSDirectorate Change
1st Apr 20213:36 pmRNSTotal Voting Rights
30th Mar 20214:21 pmRNSPublication of 2021 AGM Notice
30th Mar 202111:30 amRNSGSK respiratory product sales reporting changes
24th Mar 202112:30 pmRNSMoncef Slaoui Departs Galvani Bioelectronics
23rd Mar 20214:31 pmRNSDirector/PDMR Shareholding
17th Mar 20216:24 pmRNSChair of Audit & Risk Committee
16th Mar 202111:08 amRNSMedicago and GSK start Phase 3 trial
15th Mar 20215:27 pmRNSDirector/PDMR Shareholding
15th Mar 20217:00 amRNSAnnual Report 2020 on Form 20-F
11th Mar 20212:25 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSGSK and Vir share positive VIR-7831 data in COVID
10th Mar 20211:23 pmRNSDirector/PDMR Shareholding
9th Mar 20211:43 pmRNSAnnual Financial Report
2nd Mar 20213:48 pmRNSDirector/PDMR Shareholding
1st Mar 202110:55 amRNSTotal Voting Rights
25th Feb 202112:00 pmRNSGSK announces otilimab data for treatment of COVID
24th Feb 20211:59 pmRNSDirector/PDMR Shareholding
24th Feb 202112:13 pmRNSHolding(s) in Company
23rd Feb 20219:03 amRNSDirector/PDMR Shareholding
22nd Feb 20214:39 pmRNSDirector/PDMR Shareholding
22nd Feb 202110:40 amRNSSanofi and GSK initiate new Phase 2 study
19th Feb 202112:52 pmRNSDirector/PDMR Shareholding
19th Feb 202112:31 pmRNSDirector/PDMR Shareholding
19th Feb 202110:32 amRNSDirector/PDMR Shareholding
18th Feb 20219:59 amRNSDirector/PDMR Shareholding
17th Feb 202112:00 pmRNSGSK/Vir collaborate on antibodies for influenza
17th Feb 20219:00 amRNSDirector/PDMR Shareholding
15th Feb 202110:09 amRNSDirector/PDMR Shareholding
15th Feb 20219:15 amRNSDirector/PDMR Shareholding
12th Feb 20214:26 pmRNSDirector/PDMR Shareholding
12th Feb 20214:23 pmRNSDirector/PDMR Shareholding
12th Feb 20214:20 pmRNSDirector/PDMR Shareholding
10th Feb 20215:05 pmRNSDirector/PDMR Shareholding
10th Feb 20214:54 pmRNSDirector/PDMR Shareholding
4th Feb 202111:15 amRNSDirector/PDMR Shareholding
789101112131415

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.